Rangering i aksjer
#38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Aksjekurs
$0.08765138
Sist synkronisert: 2025-12-23
Handel Psyence Group Inc. (PSYG)
Pris PSYG pris med markedsverdi på B
Markedsverdi av Psyence Group Inc.(PSYG)
Markedsverdi: $1.11M
Per August 2026 har Psyence Group Inc. en markedsverdi på $1.11M. Dette gjør Psyence Group Inc. til det 38237th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Psyence Group Inc. fra 2021 til 2026
PSYG sammenlignet med topp 5 mest populære stocks
| Pris på PSYG |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.452T
|
+489,312,468.90%
|
|
|
|
|
$4.490T
|
+402,985,337.44%
|
|
|
|
|
$4.162T
|
+373,581,610.11%
|
|
|
|
|
$3.676T
|
+329,956,650.81%
|
|
|
|
|
$2.833T
|
+254,269,341.74%
|
